|
|
|
|
|
|
|
|
|
|
Polymorphisms and Clinical Outcome in Recurrent Ovarian Cancer Treated with Cyclophosphamide and Bevacizumab -- Schultheis et al. 14 (22): 7554 -- Clinical Cancer Research
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.